Hépato-Gastro & Oncologie Digestive
Volume 12, issue 6, Novembre-Décembre 2005
Volume 12, issue 6, Novembre-Décembre 2005
Éditorial
Recommandations pour l’hypertension portale
(p.399-401)
Dominique-Charles Valla, Didier Lebrec
Free Access
Mini-revue
Relaxations transitoires du sphincter inférieur de l’œsophage et traitement du reflux gastro-œsophagien
(p.403-7)
Abdourhamane D Diallo, Stanislas Bruley des Varannes
Free Access
Le génotype 5 du virus de l’hépatite C
(p.409-12)
Florence Legrand-Abravanel, Karine Sandres-Sauné, Christophe Pasquier, Karl Barange, Laurent Alric, Jacques Izopet
Free Access
Pronostic du malade cirrhotique en réanimation
(p.413-8)
René Robert, Hodanou Nanadoumgar
Free Access
Traitement endoscopique de l’hémorragie diverticulaire
(p.419-22)
Gilles Lesur
Free Access
Cas clinique commenté
Abdomen aigu chez un malade hémodialysé : songez au cristal
*!
(p.423-5)
Abdelkader Mordi, Christian Sevestre, Khaled Al Chaar, Véronique Debuire, Francine Lecointre, Sylvain Bauland
Free Access
Bases fondamentales
Protéomique et spectrométrie de masse : applications en clinique
(p.427-35)
Frédéric Lopez
Free Access
Informations‐BrÈves
A59. The effect of tegaserod on esophageal function : a randomized control trial in healthy volunteers.
(p.436)
Fox M, Fried M, Menne D, Stutz B, Scwizer W.
Free Access
A499. The plicator
TM procedure for the treatment of GERD : 12-month multicenter results.
(p.436)
Haber G, Sakai P, Moura E, Maluf-Fiho F, Enns R, Pleskow D, et al.
Free Access
A545. Randomised double blind cross over study evaluating the effect of intrapyloric injection of botulinum toxin on gastric emptying and symptoms in patients with gastroparesis.
(p.436)
Arts J, Canepeel P, Degreef T, Gebruers K, Verbeke K, Janssens J, Tack J.
Free Access
A407. Effect of ghrelin on gastric emptying in patients with neurogenic gastroparesis.
(p.436)
Binn M, Albert C, Gougeon A, Rabasa-Lhoret R, Havrankova J, Lemoyne M, et al.
Free Access
A901. Gastrokinetic effect of ghrelin analogue Rc-1139 on post-operative and on morphine induced ileus in rat.
(p.436)
Poitras P, Rocheleau B, Polvino W.
Free Access
A248. Application of L-erythro mÉthoxamine gel increases anal resting pressure in patients with passive faecal incontinence.
(p.436)
Nisar P, Gruss H, Bush D, Thompson J, Barras N, Scholefield J.
Free Access
A158. Post-infectious irritable bowel syndrome (IBS) after theWalkerton outbreak of waterborne gastroenteritis.
(p.436)
Marshall JK, Thabane M, Garg AX, Macnanb J, Clark W, Howard J, et al.
Free Access
A 403. Colonic mucosal mast cell mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons.
(p.436)
Barbara G, Cremon C, Riccardo V, Elisabeta C, Balestra B, Di Nardo G, et al.
Free Access
A159. Cilansetron is efficacious in treating diarrhoeal symptoms in irritable bowel syndrome with diarrhea predominance (IBS-D) over 3 months.
(p.436)
Thierry Piche, Miner PB, Pruitt RE, Carter S, Caras S, Krause G, Steinborn C.
Free Access
Combined oral and enema treatment with pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis : a randomised, double
blind, placebo controlled study.
Gut 2005 ; 54 : 960-5.
(p.436-7)
Thierry Piche, Marteau P, Probert CS, Lindgren S, Gassul M, Tan TG, Dignass A, et al.
Free Access
Growth, phenotype, and function of human intestinal mast cells are highly regulated by transforming growth factor 1. Gut 2005 ; 54 : 928-34
(p.436)
Thierry Piche, Gebhardt T, Lorentz A, Detmer F, Trautwein C, Bektas H, Manns MP, Bischoff SC.
Free Access
La radiofrÉquence selon le procÉdÉ Stretta rÉduit la distensibilitÉ de la jonction oesogastrique chez des patients ayant un RGO
(p.436)
Free Access